FDA Update: A New Chapter for Menopausal Hormone Therapy
The U.S. Food and Drug Administration (FDA) has announced it is moving forward with removing certain long-standing boxed (“black-box”) warning language from the labeling of many FDA-approved menopausal hormone therapy (MHT) products. This update reflects a comprehensive review of available scientific data and aims to better align product labeling with current clinical understanding. Importantly, this […]